Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19499560 | 0.93 | TSHR (0.39) | TSHRALDH1A1THRB | |
| SCHEMBL19499564 | 0.91 | TSHR (0.40) | TSHRALDH1A1THRB | |
| SCHEMBL395895 | 0.91 | TSHR (0.40) | TSHRALDH1A1THRB | |
| SCHEMBL8546680 | 0.84 | TSHR (0.33) | TSHRALDH1A1THRB | |
| SCHEMBL1046024 | 0.84 | TSHR (0.44) | TSHRALDH1A1THRBTDP1POLB | |
| SCHEMBL9411488 | 0.84 | TSHR (0.44) | TSHRALDH1A1THRBTDP1POLB | |
| SCHEMBL396761 | 0.84 | TSHR (0.48) | TSHRALDH1A1THRBTDP1POLB | |
| SCHEMBL396532 | 0.82 | TSHR (0.47) | TSHRALDH1A1THRBTDP1POLB | |
| SCHEMBL396535 | 0.82 | TSHR (0.42) | TSHRALDH1A1THRBTDP1POLB | |
| SCHEMBL393244 | 0.82 | TSHR (0.42) | TSHRALDH1A1THRBTDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 876 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600820-B2 | Photocurable composition with high silicon content | CANON KABUSHIKI KAISHA (JP) | 2026-04-14 | — | — | US | claimed |
| US-20250368802-A1 | PHOTOCURABLE COMPOSITION WITH HIGH SILICON CONTENT AND HIGH STABILITY | CANON KK (JP) | 2025-12-04 | — | — | US | claimed |
| US-20240199816-A1 | PHOTOCURABLE COMPOSITION WITH HIGH SILICON CONTENT | CANON KABUSHIKI KAISHA (JP) | 2024-06-20 | — | — | US | claimed |
| WO-2024123531-A1 | PHOTOCURABLE COMPOSITION WITH HIGH SILICON CONTENT | CANON KABUSHIKI KAISHA (JP) | 2024-06-13 | — | — | WO | claimed |
| US-11897985-B2 | Water extractable ophthalmic devices | BAUSCH & LOMB INCORPORATED (US) | 2024-02-13 | — | — | US | claimed |
| EP-3861039-B1 | HYDROGEL COMPOSITIONS | OPHTALMIC CIE (FR) | 2023-11-01 | — | — | EP | claimed |
| US-20220251269-A1 | WATER EXTRACTABLE OPHTHALMIC DEVICES | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2022-08-11 | — | — | US | claimed |
| EP-1945231-B1 | CONFORMABLE SOLVENT-BASED BANDAGE AND COATING MATERIAL | ROCHAL PARTNERS LLP (US) | 2021-11-10 | — | — | EP | claimed |
| EP-2764065-B1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL IND LLC (US) | 2017-03-22 | — | — | EP | claimed |
| EP-1809344-B2 | BIOMEDICAL DEVICES CONTAINING AMPHIPHILIC BLOCK COPOLYMERS | JOHNSON & JOHNSON VISION CARE (US) | 2016-08-10 | — | — | EP | claimed |
| EP-0611367-A1 | NOVEL UV CURABLE CROSSLINKING AGENTS USEFUL IN COPOLYMERIZATION. | BAUSCH & LOMB (US) | 1994-08-24 | — | — | EP | claimed |
| EP-0611380-A1 | WETTABLE SILICONE HYDROGEL COMPOSITIONS AND METHODS FOR THEIR MANUFACTURE. | BAUSCH & LOMB (US) | 1994-08-24 | — | — | EP | claimed |
| EP-0603268-A1 | WETTABLE SILICONE HYDROGEL COMPOSITIONS AND METHODS. | BAUSCH & LOMB (US) | 1994-06-29 | — | — | EP | claimed |
| EP-0603270-A1 | WETTABLE SILICONE HYDROGEL COMPOSITIONS AND METHODS FOR MAKING THEM | BAUSCH & LOMB INCORPORATED (US) | 1994-06-29 | — | — | EP | claimed |
| WO-1993023774-A1 | SURFACE WETTABLE SILICONE HYDROGELS | BAUSCH & LOMB INCORPORATED (US) | 1993-11-25 | — | — | WO | claimed |
| WO-1993009084-A1 | NOVEL UV CURABLE CROSSLINKING AGENTS USEFUL IN COPOLYMERIZATION | BAUSCH & LOMB INCORPORATED (US) | 1993-05-13 | — | — | WO | claimed |
| WO-1993009154-A1 | WETTABLE SILICONE HYDROGEL COMPOSITIONS AND METHODS FOR THEIR MANUFACTURE | BAUSCH & LOMB INCORPORATED (US) | 1993-05-13 | — | — | WO | claimed |
| WO-1993009155-A1 | WETTABLE SILICONE HYDROGEL COMPOSITIONS AND METHODS FOR THEIR MANUFACTURE | BAUSCH & LOMB INCORPORATED (US) | 1993-05-13 | — | — | WO | claimed |
| WO-1993005085-A1 | WETTABLE SILICONE HYDROGEL COMPOSITIONS AND METHODS | BAUSCH & LOMB INCORPORATED (US) | 1993-03-18 | — | — | WO | claimed |
| WO-1993005098-A1 | WETTABLE SILICONE HYDROGEL COMPOSITIONS AND METHODS | BAUSCH & LOMB INCORPORATED (US) | 1993-03-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600820-B2 | Photocurable composition with high silicon content | BIRC2, ACP1, IRS1 | TSHR 4173/4885ALDH1A1 3351/4885THRB 4666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.